<DOC>
	<DOC>NCT00990782</DOC>
	<brief_summary>This study utilizes a disposable capsule endoscope (Pillcam ESO) to assess the condition of a patient's esophagus before and after the RFA procedure, as the injury rate to the esophagus has not been established.</brief_summary>
	<brief_title>Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment</brief_title>
	<detailed_description>Patients undergoing radiofrequency ablation (RFA) therapy for atrial fibrillation, can sometimes experience insult or injury to the esophagus, due to the proximity of the esophagus to the RFA treatment area. This study utilizes a disposable capsule endoscope (Pillcam ESO) to assess the condition of a patient's esophagus before and after the RFA procedure, as the injury rate to the esophagus has not been established.</detailed_description>
	<criteria>Symptomatic patients with persistent atrial fibrillation selected for radiofrequency ablation Adults aged 18 years and older Patients able to give informed consent Patients under the age of 18 Patient unable to or unwilling to swallow the capsule endoscopes Patients with cardiac pacemakers, implanted cardiac defibrillators or other implanted electromedical devices Pregnant or lactating females Subjects with history of abdominal, pelvic, or bowel surgery within the past year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>